AMEX · Biotechnology

OGEN (OGEN) Stock

$0.50 -1.96% AMEX: OGEN Healthcare

Valuation

MetricValue
Price$0.50
Market Cap$2.26M
P/E Ratio-0.14
P/B Ratio0.44
P/S Ratio0.00
EPS (TTM)$-4.56
52-Week High$4.19
52-Week Low$0.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-311.00%
ROA-1.06%
ROCE-112.50%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-16.0M$-14.0M$-21.0M$-11.0M$-9.0M
Net Profit$-16.0M$-14.0M$-21.0M$-11.0M$-10.0M
EPS$-8.09$-7.11$-9.18$-1.60$-4.56
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$28.0M$15.0M$5.0M$1.0M$10.0M
Total Liabilities$2.0M$2.0M$2.0M$2.0M$2.0M
Cash$27.0M$11.0M$3.0M$1.0M$4.0M
Borrowings$1.0M$1.0M$0$0$0

Latest News

Oragenics Says All Three Australian Concussion Trial Sites Enrolling Patients MT Newswires · Jul 7, 2026 Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling GlobeNewswire · Jul 7, 2026 Sidoti Events, LLC's May Micro-Cap Virtual Conference ACCESS Newswire · May 20, 2026 Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21 GlobeNewswire · May 19, 2026 ORAGENICS PROVIDES INVESTOR UPDATE GlobeNewswire · May 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-15.0M$-7.0M$-9.0M$-9.2B
Investing Cash Flow$0$0$-2.0M$0$0
Financing Cash Flow$-5.0M$0$0$0$16.8B
Net Cash Flow$10.0M$-16.0M$-8.0M$-3.0M$7.5B
Free Cash Flow$-14.0M$-15.0M$-8.0M$-9.0M$-9.2B

Valuation & Return Ratios

MetricValue
PEG Ratio-8.96
EV / EBITDA—
FCF Yield-333.16%
Quick Ratio133.42
Interest Coverage-9.00
Return 1Y-58.21%
Return 3Y-99.50%
Return 5Y-99.95%

Ownership

Insiders Held1.93%
Institutions Held5.76%
Institutions Float Held5.88%
Institutional HolderSharesReport Date
Geode Capital Management, LLC65,0722026-03-31
Pathstone Holdings, LLC55,0012026-03-31
Two Sigma Securities, LLC20,3432026-03-31
HRT Financial LP18,6722026-03-31
Virtu Financial LLC17,5752026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIM $0.24 -5.84% -0.09 $801193 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%
ENSCEnsysce Biosciences, Inc. $0.26 -1.95% -0.08 $2.38M 0.00%
KALA $0.76 +3.59% -0.76 $14.62M 0.00%

About OGEN

OGEN is led by CEO Janet Huffman, employs 3 people, headquartered in US, publicly traded since 2004.

OGEN stock trades at $0.50 with a market capitalization of $2.26M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of 0.44, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.50 and $4.19, and currently trades 88.1% below its 52-week high.

On profitability, OGEN generates a return on equity (ROE) of -311.00%, return on capital employed of -112.50%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides